Image-guided surgery using invisible near-infrared light: Fundamentals of clinical translation

Molecular Imaging

Volumn 9, Issue 5, 2010, Pages 237-255

  Gioux, Sylvain ^a,b,c   Choi, Hak Soo ^a,b,c   Frangioni, John V ^a,b,c  

^a Department of Medicine   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c CEA LETI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL REALITY; CLINICAL TRANSLATION; CONTRAST AGENT; FLUORESCENCE IMAGING; FLUORESCENCE IMAGING SYSTEMS; FLUORESCENT CONTRAST AGENTS; IMAGE GUIDED SURGERY; KEY PARAMETERS; NEAR INFRARED LIGHT; NEAR-INFRARED FLUORESCENCE; OPTICAL IMAGING TECHNIQUE; PATIENT CARE; REAL-TIME IMAGES; SIGNIFICANT IMPACTS; WIDE-FIELD;

BLOOD VESSELS; FLUORESCENCE; IMAGING SYSTEMS; PATIENT REHABILITATION; SURGERY;

INFRARED DEVICES;

COMPUTER ASSISTED SURGERY; HUMAN; INFRARED RADIATION; METHODOLOGY; REVIEW;

HUMANS; INFRARED RAYS; SURGERY, COMPUTER-ASSISTED;

EID: 77958089655     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00034     Document Type: Review

References (139)

1. Frangioni JV. New technologies for human cancer imaging. J Clin Oncol 2008;26:4012-21.
2. Bani MR, Lux MP, Heusinger K, et al. Factors correlating with reexcision after breast-conserving therapy. Eur J Surg Oncol 2009;35:32-7.
3. Schiller DE, Le LW, Cho BC, et al. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy. Ann Surg Oncol 2008;15:833-42.
4. Besana-Ciani I, Greenall MJ. The importance of margins status after breast conservative surgery and radiotherapy in node positive patients: a follow-up of 10-15 years. Int Semin Surg Oncol 2008;5:13.
5. Burke S, Shorten GD. When pain after surgery doesn't go away. Biochem Soc Trans 2009;37:318-22.
6. Chance B. Near-infrared images using continuous, phasemodulated, and pulsed light with quantitation of blood and blood oxygenation. Ann N Y Acad Sci 1998;838:29-45.
7. De Grand AM, Lomnes SJ, Lee DS, et al. Tissue-like phantoms for near-infrared fluorescence imaging system assessment and the training of surgeons. J Biomed Opt 2006;11:014007.
8. Sevick-Muraca EM, Houston JP, Gurfinkel M. Fluorescenceenhanced, near infrared diagnostic imaging with contrast agents. Curr Opin Chem Biol 2002;6:642-50.
9. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003;7:626-34.
10. De Grand AM, Frangioni JV. An operational near-infrared fluorescence imaging system prototype for large animal surgery. Technol Cancer Res Treat 2003;2:553-62.
11. Nakayama A, del Monte F, Hajjar RJ, Frangioni JV. Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy. Mol Imaging 2002;1:365-77.
12. Ntziachristos V, Bremer C, Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 2003;13:195-208.
13. Tanaka E, Choi HS, Fujii H, et al. Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 2006;13:1671-81.
14. Themelis G, Yoo JS, Soh K, et al. Real-time intraoperative fluorescence imaging system using light-absorption correction. J Biomed Opt 2009;14:064012.
15. ™ intraoperative near-infrared fluorescence imaging system: a firstin-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 2009;16:2943-52.
16. Gioux S, Kianzad V, Ciocan R, et al. High-power, computercontrolled, light-emitting diode-based light sources for fluorescence imaging and image-guided surgery. Mol Imaging 2009;8:156-65.
17. Kim S, Lim YT, Soltesz EG, et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004;22:93-7.
18. Nakayama A, Bianco AC, Zhang CY, et al. Quantitation of brown adipose tissue perfusion in transgenic mice using near-infrared fluorescence imaging. Mol Imaging 2003;2:37-49.
19. ™ portable image-guided surgery system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. [Submitted]
20. Choi HS, Frangioni JV. Nanoparticles for biomedical imaging: fundamentals of clinical translation Mol Imaging 2010. [In press] DOI:10.2310/7290.2010. 00031.
21. Kiyose K, Kojima H, Nagano T. Functional near-infrared fluorescent probes. Chem Asian J 2008;3:506-15.
22. Kobayashi H, Ogawa M, Alford R, et al. New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev 2010. [In press]
23. Pierce MC, Javier DJ, Richards-Kortum R. Optical contrast agents and imaging systems for detection and diagnosis of cancer. Int J Cancer 2008;123:1979-90.
24. Te Velde EA, Veerman T, Subramaniam B, Ruers T. The use of fluorescent dyes and probes in surgical oncology. Eur J Surg Oncol 2010;36:6-15.
25. Gibbs-Strauss SL, Vooght C, Fish KM, et al. Molecular imaging agents specific for the annulus fibrosus of the intervertebral disc. Mol Imaging 2010. [In press]
26. Waterhouse RN. Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents. Mol Imaging Biol 2003;5:376-89.
27. Fagerholm U. The highly permeable blood-brain barrier: an evaluation of current opinions about brain uptake capacity. Drug Discov Today 2007;12:1076-82.
28. Strekowski L, Lipowska M, Patonay G. Substitution reactions of a nucleofugal group in heptamethine cyanine dyes. Synthesis of an isothiocyanato derivative for labeling of proteins with a nearinfrared chromophore. J Org Chem 1992;57:4578-80.
29. Narayanan N, Patonay G. A new method for the synthesis of heptamethine cyanine dyes: synthesis of new near-infrared fluorescent labels. J Org Chem 1995;60:2391-5.
30. Kiyose K, Aizawa S, Sasaki E, et al. Molecular design strategies for near-infrared ratiometric fluorescent probes based on the unique spectral properties of aminocyanines. Chemistry 2009;15:9191-200.
31. Sens R, Drexhage KH. Fluorescence quantum yield of oxazine and carbazine laser dyes. J Luminesc 1981;24:709-12.
32. Benson C, Kues HA. Absorption and fluorescence properties of cyanine dyes. J Chem Eng Data 1977;22:379-83.
33. Akers WJ, Berezin MY, Lee H, Achilefu S. Predicting in vivo fluorescence lifetime behavior of near-infrared fluorescent contrast agents using in vitro measurements. J Biomed Opt 2008;13:054042.
34. Lakowicz JR, Szmacinski H, Nowaczyk K, Johnson ML. Fluorescence lifetime imaging of free and protein-bound NADH. Proc Natl Acad Sci U S A 1992;89:1271-5.
35. Humblet V, Misra P, Frangioni JV. An HPLC/mass spectrometry platform for the development of multimodality contrast agents and targeted therapeutics: prostate-specific membrane antigen small molecule derivatives. Contrast Media Mol Imaging 2006;1:196-211.
36. Akers W, Lesage F, Holten D, Achilefu S. In vivo resolution of multiexponential decays of multiple near-infrared molecular probes by fluorescence lifetime-gated whole-body time-resolved diffuse optical imaging. Mol Imaging 2007;6:237-46.
37. Ohnishi S, Lomnes SJ, Laurence RG, et al. Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol Imaging 2005;4:172-81.
38. Choi HS, Henary M, Nasr K, et al. Ultra-low background near-infrared fluorophores for image-guided cancer surgery. [Submitted]
39. Tanaka E, Chen FY, Flaumenhaft R, et al. Real-time assessment of cardiac perfusion, coronary angiography, and acute intravascular thrombi using dual-channel near-infrared fluorescence imaging. J Thorac Cardiovasc Surg 2009;138:133-40.
40. Winer JH, Choi HS, Gibbs-Strauss SL, et al. Intraoperative localization of insulinoma and normal pancreas using invisible near-infrared fluorescent light. Ann Surg Oncol 2010;17:1094-100.
41. Matsui A, Tanaka E, Choi HS, et al. Real-time near-infrared fluorescence-guided identification of the ureters using methylene blue. Surgery 2010. [In press] DOI: 10.1016/j.surg.2010.02.014.
42. Tanaka E, Ohnishi S, Laurence RG, et al. Real-time intraoperative ureteral guidance using invisible near-infrared fluorescence. J Urol 2007;178:2197-202.
43. Matsui A, Tanaka E, Choi HS, et al. Real-time intraoperative near-infrared fluorescence identification of the extrahepatic bile ducts using clinically-available contrast agents. Surgery 2010. [In press] DOI: 10.1016/j.surg.2009.12.004.
44. Tanaka E, Choi HS, Humblet V, et al. Real-time intraoperative assessment of the extrahepatic bile ducts in rats and pigs using invisible near-infrared fluorescent light. Surgery 2008;144:39-48.
45. Alford R, Ogawa M, Choyke PL, Kobayashi H. Molecular probes for the in vivo imaging of cancer. Mol Biosyst 2009;5:1279-91.
46. Alford R, Simpson HM, Duberman J, et al. Toxicity of organic fluorophores used in molecular imaging: literature review. Mol Imaging 2009;8:341-54.
47. Ogawa M, Kosaka N, Choyke PL, Kobayashi H. Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer. Bioconjug Chem 2009;20:147-54.
48. Ogawa M, Regino CA, Choyke PL, Kobayashi H. In vivo targetspecific activatable near-infrared optical labeling of humanized monoclonal antibodies. Mol Cancer Ther 2009;8:232-9.
49. Matsui A, Lee BT, Winer JH, et al. Real-time intraoperative nearinfrared fluorescence angiography for perforator identification and flap design. Plast Reconstr Surg 2009;123:125e-7e.
50. Aoki T, Yasuda D, Shimizu Y, et al. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection. World J Surg 2008;32:1763-7.
51. Nimura H, Narimiya N, Mitsumori N, et al. Infrared ray electronic endoscopy combined with indocyanine green injection for detection of sentinel nodes of patients with gastric cancer. Br J Surg 2004;91:575-9.
52. Miyashiro I, Miyoshi N, Hiratsuka M, et al. Detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging: comparison with infrared imaging. Ann Surg Oncol 2008;15:1640-3.
53. Kusano M, Tajima Y, Yamazaki K, et al. Sentinel node mapping guided by indocyanine green fluorescence imaging: a new method for sentinel node navigation surgery in gastrointestinal cancer. Dig Surg 2008;25:103-8.
54. Fujiwara M, Mizukami T, Suzuki A, Fukamizu H. Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. J Plast Reconstr Aesthet Surg 2008;62: e373-8.
55. Tsujino Y, Mizumoto K, Matsuzaka Y, et al. Fluorescence navigation with indocyanine green for detecting sentinel nodes in extramammary Paget's disease and squamous cell carcinoma. J Dermatol 2009;36:90-4.
56. Sharma R, Wang W, Rasmussen JC, et al. Quantitative imaging of lymph function. Am J Physiol Heart Circ Physiol 2007;292: H3109-18.
57. Murawa D, Hirche C, Dresel S, Hunerbein M. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg 2009;96:1289-94.
58. Sevick-Muraca EM, Sharma R, Rasmussen JC, et al. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology 2008;246:734-41.
59. Tagaya N, Yamazaki R, Nakagawa A, et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg 2008;195:850-3.
60. Zaheer A, Lenkinski RE, Mahmood A, et al. In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol 2001;19:1148-54.
61. Figueiredo JL, Passerotti CC, Sponholtz T, et al. A novel method of imaging calcium urolithiasis using fluorescence. J Urol 2008;179:1610-4.
62. Aoki T, Murakami M, Yasuda D, et al. Intraoperative fluorescent imaging using indocyanine green for liver mapping and cholangiography. J Hepatobiliary Pancreat Surg 2010. [In press]
63. Ishizawa T, Tamura S, Masuda K, et al. Intraoperative fluorescent cholangiography using indocyanine green: a biliary road map for safe surgery. J Am Coll Surg 2009;208: e1-4.
64. Bhushan KR, Misra P, Liu F, et al. Detection of breast cancer microcalcifications using a dual-modality SPECT/NIR fluorescent probe. J Am Chem Soc 2008;130:17648-9.
65. Bhushan KR, Tanaka E, Frangioni JV. Synthesis of conjugatable bisphosphonates for molecular imaging of large animals. Angew Chem Int Ed Engl 2007;46:7969-71.
66. Liu F, Bloch N, Bhushan KR, et al. Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification. Mol Imaging 2008;7:175-86.
67. Liu F, Misra P, Lunsford EP, et al. A dose-and time-controllable syngeneic animal model of breast cancer microcalcification. Breast Cancer Res Treat 2010. [In press]
68. Gotoh K, Yamada T, Ishikawa O, et al. A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation. J Surg Oncol 2009;100:75-9.
69. Ishizawa T, Fukushima N, Shibahara J, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer 2009;115:2491-504.
70. Humblet V, Lapidus R, Williams LR, et al. High-affinity nearinfrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen. Mol Imaging 2005;4:448-62.
71. Humblet V, Misra P, Bhushan KR, et al. Multivalent scaffolds for affinity maturation of small molecule cell surface binders and their application to prostate tumor targeting. J Med Chem 2009;52:544-50.
72. Li C, Wang W, Wu Q, et al. Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl Med Biol 2006;33:349-58.
73. Kwon S, Ke S, Houston JP, et al. Imaging dose-dependent pharmacokinetics of an RGD-fluorescent dye conjugate targeted to alpha v beta 3 receptor expressed in Kaposi's sarcoma. Mol Imaging 2005;4:75-87.
74. Matsui A, Lee BT, Winer JH, et al. Quantitative assessment of perfusion and vascular compromise in perforator flaps using a near-infrared fluorescence-guided imaging system. Plast Reconstr Surg 2009;124:451-60.
75. Matsui A, Lee BT, Winer JH, et al. Image-guided perforator flap design using invisible near-infrared light and validation with x-ray angiography. Ann Plast Surg 2009;63:327-30.
76. Lee BT, Matsui A, Hutteman M, et al. Intraoperative nearinfrared fluorescence imaging in perforator flap reconstruction: current research and early clinical experience. J Reconstr Microsurg 2010;26:59-65.
77. Matsui A, Lee BT, Winer JH, et al. Submental perforator flap design with a near-infrared fluorescence imaging system: the relationship among number of perforators, flap perfusion, and venous drainage. Plast Reconstr Surg 2009;124:1098-104.
78. Newman MI, Samson MC. The application of laser-assisted indocyanine green fluorescent dye angiography in microsurgical breast reconstruction. J Reconstr Microsurg 2009;25:21-6.
79. Pestana IA, Coan B, Erdmann D, et al. Early experience with fluorescent angiography in free-tissue transfer reconstruction. Plast Reconstr Surg 2009;123:1239-44.
80. ™ intraoperative near-infrared fluorescence imaging system: a firstin-human clinical trial in perforator flap breast reconstruction. [Submitted]
81. Unno N, Suzuki M, Yamamoto N, et al. Indocyanine green fluorescence angiography for intraoperative assessment of blood flow: a feasibility study. Eur J Vasc Endovasc Surg 2008;35:205-7.
82. Rangaraj AT, Ghanta RK, Umakanthan R, et al. Real-time visualization and quantification of retrograde cardioplegia delivery using near infrared fluorescent imaging. J Card Surg 2008;23:701-8.
83. Soltesz EG, Laurence RG, De Grand AM, et al. Image-guided quantification of cardioplegia delivery during cardiac surgery. Heart Surg Forum 2007;10: E381-6.
84. Balacumaraswami L, Abu-Omar Y, Choudhary B, et al. A comparison of transit-time flowmetry and intraoperative fluorescence imaging for assessing coronary artery bypass graft patency. J Thorac Cardiovasc Surg 2005;130:315-20.
85. Balacumaraswami L, Taggart DP. Digital tools to facilitate intraoperative coronary artery bypass graft patency assessment. Semin Thorac Cardiovasc Surg 2004;16:266-71.
86. Balacumaraswami L, Taggart DP. Intraoperative imaging techniques to assess coronary artery bypass graft patency. Ann Thorac Surg 2007;83:2251-7.
87. Chang K, Jaffer F. Advances in fluorescence imaging of the cardiovascular system. J Nucl Cardiol 2008;15:417-28.
88. Desai ND, Miwa S, Kodama D, et al. Improving the quality of coronary bypass surgery with intraoperative angiography: validation of a new technique. J Am Coll Cardiol 2005;46:1521-5.
89. Desai ND, Miwa S, Kodama D, et al. A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts. J Thorac Cardiovasc Surg 2006;132:585-94.
90. Detter C, Wipper S, Russ D, et al. Fluorescent cardiac imaging: a novel intraoperative method for quantitative assessment of myocardial perfusion during graded coronary artery stenosis. Circulation 2007;116:1007-14.
91. Di Giammarco G, Pano M, Cirmeni S, et al. Predictive value of intraoperative transit-time flow measurement for short-term graft patency in coronary surgery. J Thorac Cardiovasc Surg 2006;132:468-74.
92. Sekijima M, Tojimbara T, Sato S, et al. An intraoperative fluorescent imaging system in organ transplantation. Transplant Proc 2004;36:2188-90.
93. Taggart DP, Balacumaraswami L, Venkatapathy A. Radial artery jump graft from anterior to posterior descending coronary artery. Asian Cardiovasc Thorac Ann 2009;17:143-6.
94. Taggart DP, Choudhary B, Anastasiadis K, et al. Preliminary experience with a novel intraoperative fluorescence imaging technique to evaluate the patency of bypass grafts in total arterial revascularization. Ann Thorac Surg 2003;75:870-3.
95. Veerman T, Haussler A, Genoni M, et al. Novadaq SPY: intraoperative quality assessment in off-pump coronary artery bypass grafting. Chest 2004;125:418-24.
96. Waseda K, Ako J, Hasegawa T, et al. Intraoperative fluorescence imaging system for on-site assessment of off-pump coronary artery bypass graft. JACC Cardiovasc Imaging 2009;2:604-12.
97. Yasuda T, Watanabe G, Tomita S. Transaortic injection technique in fluorescence imaging: novel intraoperative assessment of anastomosis in off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 2005;130:560-1.
98. Zaheer A, Murshed M, De Grand AM, et al. Optical imaging of hydroxyapatite in the calcified vasculature of transgenic animals. Arterioscler Thromb Vasc Biol 2006;26:1132-6.
99. Flaumenhaft R, Tanaka E, Graham GJ, et al. Localization and quantification of platelet-rich thrombi in large blood vessels with near-infrared fluorescence imaging. Circulation 2007;115:84-93.
100. Bruneau M, Sauvageau E, Nakaji P, et al. Preliminary personal experiences with the application of near-infrared indocyanine green videoangiography in extracranial vertebral artery surgery. Neurosurgery 2010;66:305-11; discussion 311.
101. Imizu S, Kato Y, Sangli A, et al. Assessment of incomplete clipping of aneurysms intraoperatively by a near-infrared indocyanine green-video angiography (Niicg-Va) integrated microscope. Minim Invasive Neurosurg 2008;51:199-203.
102. Uluc K, Kujoth GC, Baskaya MK. Operating microscopes: past, present, and future. Neurosurg Focus 2009;27: E4.
103. Gibbs-Strauss SL, Nasr KA, Fish KM, et al. Nerve-highlighting fluorescent contrast agents for image-guided surgery. Mol Imaging 2010. [In press]
104. Gibbs-Strauss SL, Rosenberg M, Clough BL, et al. First-in-human clinical trials of imaging devices: an example from optical imaging. Conf Proc IEEE Eng Med Biol Soc 2009;1:2001-4.
105. Guidance for industry, investigators, and reviewers: exploratory IND studies. 2006. Available at: www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM078933.pdf (accessed January 1, 2010).
106. Mills G. The exploratory IND. J Nucl Med 2008;49:45N-7N.
107. Skovronsky D. Use of eINDs for evaluation of multiple related PET amyloid plaque imaging agents. J Nucl Med 2008;49:47N-8N.
108. Lakowicz JR, Berndt KW. Lifetime-selective fluorescence imaging using an rf phase-sensitive camera. Rev Sci Instrum 1991;62:1727-34.
109. Lakowicz JR, Szmacinski H, Nowaczyk K, et al. Fluorescence lifetime imaging. Anal Biochem 1992;202:316-30.
110. Hutchinson CL, Lakowicz JR, Sevick-Muraca EM. Fluorescence lifetime-based sensing in tissues: a computational study. Biophys J 1995;68:1574-82.
111. O'Leary MA, Boas DA, Li XD, et al. Fluorescence lifetime imaging in turbid media. Opt Lett 1996;21:158-60.
112. Gioux S, Lomnes SJ, Choi HS, Frangioni JV. Low-frequency widefield fluorescence lifetime imaging using a high-power nearinfrared LED light source. J Biomed Opt 2010;15:026005.
113. May A, Bhaumik S, Gambhir SS, et al. Whole-body, real-time preclinical imaging of quantum dot fluorescence with time-gated detection. J Biomed Opt Let 2009;14:060504.
114. Munro I, McGinty J, Galletly N, et al. Toward the clinical application of time-domain fluorescence lifetime imaging. J Biomed Opt 2005;10:051403.
115. Requejo-Isidro J, McGinty J, Munro I, et al. High-speed widefield time-gated endoscopic fluorescence-lifetime imaging. Opt Lett 2004;29:2249-51.
116. Patterson MS, Chance B, Wilson B. Time resolved reflectance and transmittance for the noninvasive measurement of tissue optical properties. Appl Opt 1989;28:2331-6.
117. Farrell TJ, Patterson MS, Wilson B. A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo. Med Phys 1992;19:879-88.
118. Patterson MS, Pogue BW. Mathematical model for time-resolved and frequency-domain fluorescence spectroscopy in biological tissues. Appl Opt 1994;33:1963-74.
119. Kienle A, Lothar L, Patterson MS, et al. Spatially resolved absolute diffuse reflectance measurements for noninvasive determination of the optical scattering and absorption coefficients of biological tissues. Appl Opt 1996;35:2304-14.
120. Cuccia DJ, Bevilacqua F, Durkin AJ, et al. Quantitation and mapping of tissue optical properties using modulated imaging. J Biomed Opt 2009;14:024012.
121. Cuccia DJ, Bevilacqua F, Durkin AJ, Tromberg BJ. Modulated imaging: quantitative analysis and tomography of turbid media in the spatial-frequency domain. Opt Lett 2005;30:1354-6.
122. Dognitz N, Wagnieres G. Determination of tissue optical properties by steady-state spatial frequency-domain reflectometry. Lasers Med Sci 1998;13:55-65.
123. Gioux S, Mazhar A, Cuccia DJ, et al. Three-dimensional surface profile intensity correction for spatially modulated imaging. J Biomed Opt 2009;14:034045.
124. Konecky SD, Mazhar A, Cuccia D, et al. Quantitative optical tomography of sub-surface heterogeneities using spatially modulated structured light. Opt Express 2009;17:14780-90.
125. Mazhar A, Cuccia DJ, Gioux S, et al. Structured illumination enhances resolution and contrast in thick tissue fluorescence imaging. J Biomed Opt 2010;15:010506.
126. Gioux S, Ashitate Y, Hutteman M, Frangioni JV. Motion-gated acquisition for in vivo optical imaging. J Biomed Opt 2009;14:064038.
127. Cerussi A, Shah N, Hsiang D, et al. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt 2006;11:044005.
128. Fishkin JB, Coquoz O, Anderson ER, et al. Frequency-domain photon migration measurements of normal and malignant tissue optical properties in a human subject. Appl Opt 1997;36:10-20. (Pubitemid 127615546)
129. Tromberg BJ, Shah N, Lanning R, et al. Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2000;2:26-40.
130. Boyer JC, Manseau MP, Murray JI, van Veggel FC. Surface modification of upconverting NaYF (4) nanoparticles with PEG-phosphate ligands for NIR (800 nm) biolabeling within the biological window. Langmuir 2010;26:1157-64.
131. Asanuma D, Kobayashi H, Nagano T, Urano Y. Fluorescence imaging of tumors with "smart" pH-activatable targeted probes. Methods Mol Biol 2009;574:47-62.
132. Lee H, Mason JC, Achilefu S. Heptamethine cyanine dyes with a robust C-C bond at the central position of the chromophore. J Org Chem 2006;71:7862-5.
133. Lebeuf R, Ferezou I, Rossier J, et al. Straightforward synthesis of the near-infrared fluorescent voltage-sensitive dye RH1691 and analogues thereof. Org Lett 2009;11:4822-5.
134. Matiukas A, Mitrea BG, Pertsov AM, et al. New near-infrared optical probes of cardiac electrical activity. Am J Physiol Heart Circ Physiol 2006;290: H2633-43.
135. Walton RD, Mitrea BG, Pertsov AM, Bernus O. A novel nearinfrared voltage-sensitive dye reveals the action potential wavefront orientation at increased depths of cardiac tissue. Conf Proc IEEE Eng Med Biol Soc 2009;1:4523-6.
136. Ntziachristos V, Yodh AG, Schnall M, Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A 2000;97:2767-72.
137. Choi HS, Liu W, Liu F, et al. Design considerations for tumourtargeted nanoparticles. Nat Nanotechnol 2010;5:42-7.
138. Choi HS, Liu W, Misra P, et al. Renal clearance of quantum dots. Nat Biotechnol 2007;25:1165-70.
139. Liu W, Choi HS, Zimmer JP, et al. Compact cysteine-coated CdSe (ZnCdS) quantum dots for in vivo applications. J Am Chem Soc 2007;129:14530-1.